Crossmark

The Finnish Interprofessional Medication Assessment (FIMA): baseline findings from home care setting

Crossref DOI link: https://doi.org/10.1007/s40520-018-1085-8

Published Online: 2018-12-05

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Auvinen, K. https://orcid.org/0000-0003-4832-8497
Räisänen, J.

Merikoski, M.

Mäntylä, A.

Kumpusalo-Vauhkonen, A.

Enlund, H.

Liukkonen, T.

Jyrkkä, J. https://orcid.org/0000-0003-4929-441X
Lönnroos, E.

Mäntyselkä, P. https://orcid.org/0000-0002-5236-1815
Funding

Funding for this research was provided by:

Sosiaali- ja Terveysministeriö

Etelä-Savon Rahasto (12172075)

Uulo Arhio Foundation

Avohoidon tutkimussäätiö
License Information

Text and Data Mining valid from 2018-12-05
More Information

Article History

Received: 30 August 2018

Accepted: 21 November 2018

First Online: 5 December 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interests.

: The FIMA study protocol was approved by the Research Ethics Committee of Northern Savo Hospital District and Kuopio University Hospital. The FIMA study is registered at ClinilcaTrials.gov (), registration date: is 20th March 2015.

: Written informed consent was obtained from all individual patients included in the study or their closest proxy if the patient had diagnosed dementia or suspected cognitive impairment.